Crinetics Pharmaceuticals - 53 Year Dividend History | CRNX

Historical dividend payout and yield for Crinetics Pharmaceuticals (CRNX) since 1971. The current TTM dividend payout for Crinetics Pharmaceuticals (CRNX) as of December 20, 2024 is $0.00. The current dividend yield for Crinetics Pharmaceuticals as of December 20, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.891B $0.004B
Crinetics Pharmaceuticals Inc is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's product pipeline consists of CRN00808 for the treatment of Acromegaly, CRN02481 for the treatment of Hyperinsulinemias and CRN01941 for the treatment of Neuroendocrine Tumors which are in clinical stage. Crinetics Pharmaceuticals Inc is based in San Diego, United States.
Stock Name Country Market Cap PE Ratio